Bhavesh Ashar - Apr 1, 2022 Form 4 Insider Report for SpringWorks Therapeutics, Inc. (SWTX)

Role: Chief Commercial Officer
Signature: /s/ Francis I. Perier, Jr. as Attorney-in Fact
Stock symbol: SWTX
Transactions as of: Apr 1, 2022
Transactions value $: -$83,302
Form type: 4
Date filed: 10/13/2022, 04:03 PM
Previous filing: Jan 10, 2022
Next filing: Jan 9, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	SWTX	Common Stock	Tax liability	-$83.3K	-1.46K	-5.73%	$56.90	24.1K	Apr 1, 2022	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	SWTX	Stock Option (Right to Buy)	Award	$0	+100K		$0.00	100K	Oct 11, 2022	Common Stock	100K	$26.98	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of restricted stock units and does not represent a sale by the Reporting Person.
F2	Twenty-five percent (25%) of this option shall vest and become exercisable on October 11, 2023, with the remaining seventy-five percent (75%) to vest in thirty-six (36) equal monthly installments thereafter subject to continued service to the Issuer by the Reporting Person.